BayWa's Dual Crisis: A €2.7 Billion Hole and a Legal Storm

German trader BayWa battles a €2.7B funding shortfall and a legal probe into past management, putting its StaRUG restructuring plan and creditor standstill at risk.

The fate of German agricultural trader BayWa rests on a precarious two-front battle. While its management scrambles to close a massive €2.7 billion funding shortfall in its restructuring plan, the company is simultaneously engulfed by a legal investigation that threatens to undermine its credibility with investors and creditors alike.

Financially, the situation is stark. The company’s overarching "StaRUG" restructuring plan, finalized in May 2025, targets a total of €4 billion in financial relief. Yet, a yawning gap remains. The recent collapse of a planned partial sale of the renewable energy division, following cuts to U.S. subsidies, wiped out an expected €1.7 billion. This leaves the company desperately reliant on asset disposals that are proving difficult and insufficient.

A €107 million payment due at the end of April, stemming from the sale of grain subsidiary Cefetra, offers little more than a temporary liquidity boost. Combined with roughly €62 million from shareholder loan repayments, the funds are primarily intended as negotiating leverage with creditor banks DZ Bank and HVB. Their consent to extend a standstill agreement until autumn 2026 is the linchpin of the entire rescue effort. Without it, the restructuring plan loses its legal foundation.

The pressure is acutely felt by BayWa's core owners, the Bavarian cooperative banks. As both major shareholders and primary lenders, they face losses on both sides of the balance sheet. They have already written down 60% of a €220 million promissory note, a €132 million hit, and have been advised to prepare for further—potentially total—impairments. Over the past two years, these institutions have funneled approximately €550 million into BayWa via capital increases and loans.

Asset sales are progressing slowly. The majority stake in profitable fruit trader T&G Global, which posted a 2024 net profit of $16 million, is on the block with Goldman Sachs managing the sale. However, complications with a Chinese minority shareholder are delaying a deal. The anticipated €300 million in proceeds would barely make a dent in the financial gap.

Compounding the financial distress is a growing governance and legal crisis. Munich's public prosecutor is investigating former board members for breach of trust, alleging they concealed liquidity risks in the 2023 financial statements. Financial watchdog BaFin has formally reprimanded the company, paving the way for the first investor lawsuits. Internally, the supervisory board is weakening, with three members departing this spring and no successors named. In response, the board has drastically lowered the approval threshold for transactions from €200 million to €50 million.

Investors are navigating in the dark. Due to complex revaluations, the audited group financial statements for 2025 will not be published until the fourth quarter of 2026. Auditor PwC will issue its final certification for the current fiscal year before handing over the mandate from 2026 onward.

Management's radical restructuring blueprint, stretching to 2028, outlines severe cuts: a focus on four core business areas, the elimination of around 1,300 jobs, a reduction in revenue to approximately €10 billion, and a slashed EBITDA target of €140 million for 2027.

The share price reflects the profound uncertainty. Trading around €13.40, the stock has shed about one-fifth of its value since the start of the year and sits roughly 38% below its annual high of €21.50. The coming weeks will determine if the April payment can buy enough goodwill from creditors to keep the fragile restructuring alive, or if the twin pressures of financial necessity and legal jeopardy will prove overwhelming.